- Home
- NCSM vs ABOS Comparison
NCSM vs ABOS Comparison
Compare NCSM & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NCSM | ABOS |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.3M | 114.5M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NCSM | ABOS |
|---|---|---|
| Price | $40.25 | $1.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 9.1K | ★ 203.9K |
| Earning Date | 03-09-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.53 | N/A |
| Revenue | ★ $178,000,000.00 | N/A |
| Revenue This Year | $11.25 | N/A |
| Revenue Next Year | $7.76 | N/A |
| P/E Ratio | $8.72 | ★ N/A |
| Revenue Growth | ★ 16.49 | N/A |
| 52 Week Low | $23.89 | $0.86 |
| 52 Week High | $53.69 | $2.46 |
Technical Indicators
Market Signals| Indicator | NCSM | ABOS |
|---|---|---|
| Relative Strength Index (RSI) | 53.42 | 51.43 |
| Support Level | $38.64 | $1.76 |
| Resistance Level | $41.21 | $2.03 |
| Average True Range (ATR) | 1.60 | 0.15 |
| MACD | 0.14 | 0.00 |
| Stochastic Oscillator | 84.54 | 60.53 |
Price Performance
Historical ComparisonAbout NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.